AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Inyx's Ashton subsidiary to manufacture and package prescription product for Acorus Therapeutics.
(From Chemical Business NewsBase - Press Release)
Inyx Inc announced that its wholly owned UK subsidiary Ashton Pharmaceuticals (Ashton) has been selected by Acorus Therapeutics Ltd to manufacture and package a prescription-only, solid-dose product for the treatment of various forms of epilepsy and essential tremor. Ashton is in the process of concluding process validation, method transfer and stability studies to permit commercial production of this drug to commence. Acorus and Ashton have now signed an initial three-year agreement …
